Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SpinalCyte Announces New Australian Patent - Orthopedic Design & Technology
OEM News

SpinalCyte Announces New Australian Patent

The patented tech involves producing chondrocytes or chondrocyte-like cells using fibroblasts in vivo.

SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the issuance of Australian Patent No. 2015202319, “Methods And Compositions For Repair of Cartilage Using An In Vivo Bioreactor.”
 
The technology described in the patent involves producing chondrocytes or chondrocyte-like cells using fibroblasts in vivo with mechanical stress and low oxygen tension.
 
“This Australian patent covers our core technology and provides the foundation for our intellectual property protection internationally. It solidifies our scientific basis and protects our technology in an extremely important market,” said Pete O’Heeron, CEO, SpinalCyte.
 
With this addition, SpinalCyte’s portfolio now includes 24 U.S. and foreign patents issued and directly owned by the company, along with 45 patents pending.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters